Hematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHistocompatibility TestingHematopoietic Stem CellsHepatic Veno-Occlusive DiseaseStem CellsTreatment OutcomeBone Marrow TransplantationTransplantation ChimeraImmunosuppressive AgentsImmunocompromised HostTissue DonorsGraft SurvivalRetrospective StudiesMyeloablative AgonistsGraft vs Leukemia EffectBusulfanRecurrenceRemission InductionLeukemiaLiver TransplantationVidarabineGraft vs Tumor EffectCord Blood Stem Cell TransplantationMultiple MyelomaWhole-Body IrradiationCombined Modality TherapyStem Cell NicheMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteLymphocyte TransfusionAntigens, CD34HistocompatibilityCell DifferentiationTransplantationKidney TransplantationSiblingsHLA AntigensAdult Stem CellsAnemia, AplasticSurvival AnalysisSalvage TherapyCell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDisease-Free SurvivalSurvival RateCytomegalovirus InfectionsMelphalanHematopoiesisLymphocyte DepletionMyelodysplastic SyndromesEmbryonic Stem CellsAntilymphocyte SerumMinor Histocompatibility AntigensTime FactorsHematopoietic Stem Cell MobilizationChimerismFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideNeoplasm, ResidualAntineoplastic Combined Chemotherapy ProtocolsVirus ActivationMice, Inbred C57BLTransplantation ImmunologyBone Marrow CellsFlow CytometryT-LymphocytesBone MarrowCell LineageHematologic DiseasesAcute DiseaseHeart TransplantationImmunosuppressionGraft RejectionPancytopeniaCytomegalovirusCells, CulturedTransplantation, IsogeneicPrognosisPluripotent Stem CellsCytarabineFetal BloodCell ProliferationLung TransplantationPrimary MyelofibrosisLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorHodgkin DiseaseNeural Stem CellsMesenchymal Stromal CellsLeukemia, MyeloidLymphoproliferative DisordersAntineoplastic Agents